Cargando…

Exosomes as a predictor tool of acquired resistance to melanoma treatment

Detalles Bibliográficos
Autores principales:	Goedert, Lucas, Koya, Richard, Hu-Lieskovan, Siwen, Ribas, Antoni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204024/ http://dx.doi.org/10.1186/1753-6561-8-S4-P28

Ejemplares similares

Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma
por: Homet Moreno, Blanca, et al.
Publicado: (2015)

What does PD-L1 positive or negative mean?
por: Ribas, Antoni, et al.
Publicado: (2016)

Innate resistance of PD-1 blockade through loss of function mutations in JAK resulting in inability to express PD-L1 upon interferon exposure
por: Shin, Daniel, et al.
Publicado: (2015)

Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition
por: Mok, Stephen, et al.
Publicado: (2015)

Antibody blockade of semaphorin 4D breaks down barriers to enhance tumoricidal immune infiltration and supports rational immunotherapy combinations
por: Evans, Elizabeth E, et al.
Publicado: (2015)

Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma
por: Stucci, Stefania, et al.
Publicado: (2015)

Predictors of toxicity for metastatic melanoma patients treated with ipilimumab
por: Valpione, Sara, et al.
Publicado: (2015)

Serum immunoregulatory proteins as predictors of overall survival of metastatic melanoma patients treated with ipilimumab
por: Koguchi, Yoshinobu, et al.
Publicado: (2015)

6. Treatment resistant ulcerating dermatomyositis in metastatic melanoma treated with checkpoint inhibitor therapy
por: Parker, Lucy, et al.
Publicado: (2019)

A Phase I/III, multicenter, open-label trial of talimogene laherparepvec (T-VEC) in combination with pembrolizumab for the treatment of unresected, stage IIIb-IV melanoma (MASTERKEY-265)
por: Long, Georgina V, et al.
Publicado: (2015)

Comparison of CURB-65 and CRB-65 as predictors of death in community-acquired pneumonia in adults admitted to an ICU
por: Santana, AR, et al.
Publicado: (2013)

HLA-DR monocyte antigen expression as predictors of outcome in patients with community-acquired infections presenting with fever
por: Logothetis, D, et al.
Publicado: (2015)

Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)
por: Hodi, F Stephen, et al.
Publicado: (2014)

Single-cell motility and gene expression signature as predictors of the overall survival of act in melanoma patients
por: Martinez-Paniagua, Melisa, et al.
Publicado: (2015)

B16F0 melanoma exosomes deliver a unique and complex biological payload that includes Ptpn11 to suppress T lymphocyte function
por: Wu, Yueting, et al.
Publicado: (2015)

Risk of acquiring drug-resistant (MDR) Gram-negative isolates with previous exposure to antibiotic
por: Bhakta, A, et al.
Publicado: (2010)

Electrotransfer of IL-15/IL-15Rα complex for the treatment of established melanoma
por: Shirley, Shawna, et al.
Publicado: (2015)

An image analysis algorithm based on the hue saturation density transformation, an important tool for melanoma immunotherapy research
por: Dzubay, Jeffrey A, et al.
Publicado: (2014)

Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-κB or the PI3K/mTOR signalling pathway
por: Caporali, Simona, et al.
Publicado: (2015)

A cell-based model of pathological tau uptake and propagation
por: Falcon, Ben, et al.
Publicado: (2013)

Barasertib: a novel approach for the treatment of metastatic melanoma
por: Azzariti, Amalia, et al.
Publicado: (2014)

Community-acquired methicillin-resistant Staphylococcus auereus in a Malaysian tertiary centre in year 2009
por: Zainol Rashid, Z, et al.
Publicado: (2011)

First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma
por: Wang, Xuechen, et al.
Publicado: (2021)

Detection of antibody therapy-induced anti-tumor immune responses using anti-CD8 immuno-pet
por: Tavare, Richard, et al.
Publicado: (2015)

Immunotherapeutic targeting of HSP90 client proteins in BRAF-inhibitor resistant melanoma
por: Fecek, Ronald J, et al.
Publicado: (2015)

Melanoma whole exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance
por: Shi, Hubing, et al.
Publicado: (2012)

The TiltMeter app is a novel and accurate measurement tool for the weight bearing lunge test
por: Williams, Cylie, et al.
Publicado: (2013)

Methicillin-resistant Staphylococcus aureus infection acquired in intensive care: a prospective study of infection and outcome
por: MacNeil, C, et al.
Publicado: (2004)

Telavancin for the treatment of hospital-acquired pneumonia in severely ill and older patients: the ATTAIN studies
por: Rubinstein, E, et al.
Publicado: (2009)

Exome sequencing identifies somatic point mutations associated with acquired endocrine resistance in breast cancer cell lines
por: Ehlers, Natasja S, et al.
Publicado: (2012)

Community acquired vs hospital acquired acute kidney injury. mortality and timing of renal replacement therapy
por: Moreno-Gonzalez, G, et al.
Publicado: (2015)

Harnessing the potential of radiation treatment of brain metastases to improve melanoma immunotherapy
por: McNeilly, Corey D, et al.
Publicado: (2015)

Platelet-derived exosomes are redox signaling particles
por: Gambim, MH, et al.
Publicado: (2007)

Feasibility of dc vaccine combined with low dose endoxan and high dose il-2 treatment associated with taurolidine for advanced, multi-resistant melanoma patients.
por: Moviglia, Gustavo A, et al.
Publicado: (2015)

Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma
por: Dharanipragada, Prashanthi, et al.
Publicado: (2023)

Community-acquired pneumonia treated on the ICU
por: Apostolidou, E, et al.
Publicado: (2006)

Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1
por: Hiscox, S, et al.
Publicado: (2008)

Clinical value of Melanoma Inhibitory Activity in stratifying malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015)

Exome sequencing in primary melanoma identifies novel drivers of melanoma progression
por: Montagnani, Valentina, et al.
Publicado: (2015)

Purine nucleoside phosphorylase inhibitors - an immunotherapy with novel mechanism of action for the treatment of melanoma
por: Bantia, Shanta
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j5ifebilarfu3f2ddes64v95n4